U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
INCLACUMAB
A6734I702L
Investigational
General
Names
10
Classification
1
Identifiers
11
Subunits
4
Related Substances
1
INCLACUMAB
A6734I702L
Investigational
General
Approval Year
Unknown
149,124
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
LC-1004-002
Preferred Name
English
INCLACUMAB
Official Name
English
Inclacumab [WHO-DD]
Common Name
English
inclacumab [INN]
Common Name
English
RG-1512
Code
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of Sickle Cell Disease
FDA ORPHAN DRUG
875522
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
ZZ-135
PRIMARY
INN
9512
PRIMARY
CAS
1256258-86-2
PRIMARY
WIKIPEDIA
Inclacumab
PRIMARY
ChEMBL
CHEMBL2109487
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
A6734I702L
INCLACUMAB